Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Harrington Wellness is a private U.S. cannabis wellness company founded by former NBA player Al Harrington in 2018. The company develops and markets hemp-derived cannabinoid consumer health products, with its flagship brand re+PLAY focused on sports recovery, mobility, and everyday wellness for athletes and active consumers. Its currently marketed portfolio emphasizes topical CBD-based formulations, including recovery gel and recovery cream products, and recent launches have incorporated CBD + CBG formulations developed with Avicanna. Harrington Wellness appears to operate primarily as a branded commercial wellness business rather than a drug-development biotech company, and there is no evidence of a clinical-stage therapeutic pipeline. The company is headquartered in Los Angeles and sells products direct-to-consumer through replaycbd.com.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Harrington Wellness.